Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel

by Zuzana Motovska, Petr Widimsky
Published 2009-05-01

Mortality in patients with TIMI 3 flow after PCI in relation to time delay to reperfusion

by Teodora Vichova, Marek Maly, Jaroslav Ulman, Zuzana Motovska
Published 2016-03-01

Association of polymorphisms of platelet receptors GPIa (807C>T), GPVI (13254T>C), and P2Y12 (34C>T and H1/H2 haplotype) with increased risk of periprocedural bleeding in patients...

by Magdalena Sionova, Peter Blasko, Stepan Jirous, David Vindis, Richard Rokyta, Zuzana Motovska
Published 2017-09-01

Modified Strategies for Invasive Management of Acute Coronary Syndrome during the COVID-19 Pandemic

by Petr Toušek, Viktor Kocka, Petr Masek, Petr Tuma, Marek Neuberg, Markéta Novackova, Josef Kroupa, David Bauer, Zuzana Motovska, Petr Widimsky
Published 2021-12-01

A contemporary approach to a young female patient with Loeys-Dietz syndrome and an uncomplicated type B aortic dissection: a case report

by Petko Prodanov, Hana Linkova, Robert Petr, Richard Fojt, Zuzana Motovska, Jiri Knot, Filip Rohac, Boris Koznar, Mariwan Majid, Petr Widimsky, Petr Kacer
Published 2020-08-01

Antithrombotic therapy of patients with atrial fibrillation discharged after major non-cardiac surgery. 1-year follow-up. Sub-analysis of PRAGUE 14 study.

by Martina Ondrakova, Zuzana Motovska, Petr Waldauf, Jiri Knot, Lukas Havluj, Lukas Bittner, Radek Bartoska, Robert Gűrlich, Martin Krbec, Valer Dzupa, Robert Grill, Petr Widimsky
Published 2017-01-01

MiR-126-3p and MiR-223-3p as Biomarkers for Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty

by Milan Hromadka, Zuzana Motovska, Ota Hlinomaz, Petr Kala, Frantisek Tousek, Jiri Jarkovsky, Marketa Beranova, Pavel Jansky, Michal Svoboda, Iveta Krepelkova, Richard Rokyta, Petr Widimsky, Michal Karpisek
Published 2021-06-01

The Effect of Diabetes on Prognosis Following Myocardial Infarction Treated with Primary Angioplasty and Potent Antiplatelet Therapy

by Stanislav Simek, Zuzana Motovska, Ota Hlinomaz, Petr Kala, Milan Hromadka, Jiri Knot, Ivo Varvarovsky, Jaroslav Dusek, Richard Rokyta, Frantisek Tousek, Michal Svoboda, Alexandra Vodzinska, Jan Mrozek, Jiri Jarkovsky, and on behalf of the PRAGUE‐18 Study Group
Published 2020-08-01